Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03374839
Title Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients (Nivo-TIL)
Acronym Nivo-TIL
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nantes University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.